Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2

Microbes and Infection

Volumn 13, Issue 4, 2011, Pages 350-358

  Sawahata, Ryoko ^a   Shime, Hiroaki ^a   Yamazaki, Sayuri ^a   Inoue, Norimitsu ^b   Akazawa, Takashi ^b   Fujimoto, Yukari ^c   Fukase, Koichi ^c   Matsumoto, Misako ^a   Seya, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Medical Center for Cancer   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Macrophage activating lipopeptide 2; MyD88; NK activation; Toll like receptor 2

Indexed keywords

AMINO ACID; INTERLEUKIN 12P40; INTERLEUKIN 6; LIPOPEPTIDE; LIPOPEPTIDE PAM2CSK; LIPOPEPTIDE PAM2CSK4; LIPOPEPTIDE PAM2CYS12; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; MACROPHAGE ACTIVATING LIPOPEPTIDE 2F; MACROPHAGE ACTIVATING LIPOPEPTIDE 2S; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GROWTH RETARDATION; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MOUSE; MYCOPLASMA; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; HEK293 CELLS; HUMANS; KILLER CELLS, NATURAL; LIPOPEPTIDES; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOPLASMA; MYELOID DIFFERENTIATION FACTOR 88; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TRANSPLANTATION, HETEROLOGOUS;

MYCOPLASMA;

EID: 79952451366     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.12.003     Document Type: Article

References (34)

1. Seya T., Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int. J. Biochem. Cell Biol. 2002, 34:901-906.
2. Matsumoto M., Nishiguchi M., Kikkawa S., Nishimura H., Nagasawa S., Seya T. Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes. J. Biol. Chem. 1998, 273:12407-12414.
3. Matsumoto M., Takeda J., Inoue N., Hara T., Hatanaka M., Takahashi K., Nagasawa S., Akedo H., Seya T. A novel protein that participates in non-self discrimination of malignant cells by homologous complement. Nat. Med. 1997, 3:1266-1270.
4. Davis K.L., Wise K.S. Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans. Infect. Immun. 2002, 70:1129-1135.
5. Mühlradt P.F., Kiess M., Meyer H., Süssmuth R., Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 1997, 185:1951-1958.
6. Schmidt J., Welsch T., Jäger D., Mühlradt P.F., Büchler M.W., Märten A. Intratumoral injection of the Toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial. Br. J. Cancer 2007, 97:598-604.
7. Haller D., Serrant P., Granato D., Schiffrin E.J., Blum S. Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin. Diagn. Lab. Immunol. 2002, 9:649-657.
8. Miyake T., Kumagai Y., Kato H., Guo Z., Matsushita K., Satoh T., Kawagoe T., Kumar H., Jang M.H., Kawai T., Tani T., Takeuchi O., Akira S. Poly I: C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J. Immunol. 2009, 183:2522-2528.
9. McCartney S., Vermi W., Gilfillan S., Cella M., Murphy T.L., Schreiber R.D., Murphy K.M., Colonna M. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J. Exp. Med. 2009, 206:2967-2976.
10. Akazawa T., Okuno M., Okuda Y., Tsujimura K., Takahashi T., Ikawa M., Okabe M., Ebihara T., Shingai M., Inoue N., Tanaka-Okamoto M., Ishizaki H., Miyoshi J., Matsumoto M., Seya T. Antitumor NK activation induced by the Toll-like receptor3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc. Natl. Acad. Sci. U S A 2007, 104:252-257.
11. Akao Y., Ebihara T., Masuda H., Saeki Y., Hazeki K., Hazeki O., Matsumoto M., Seya T. Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice. Cancer Sci. 2009, 100:1494-1501.
12. Azuma M., Sawahata R., Akao Y., Ebihara T., Yamazaki S., Matsumoto M., Hashimoto M., Fukase K., Fujimoto Y., Seya T. The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation. PLoS One 2010, 5:e12550.
13. Fujimoto Y., Hashimoto M., Furuyashiki M., Katsumoto M., Seya T., Suda Y., Fukase K. Innate immunostimulatory lipopeptides of Staphylococcus aureus as TLR2 ligands; Prediction with mRNA expression, chemical synthesis and immunostimulatory activities. Chembiochem 2009, 10:2311-2315.
14. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
15. Tanaka H., Mori Y., Ishii H., Akedo H. Enhancement of metastatic capacity of fibroblast-tumor cell interaction in mice. Cancer Res. 1988, 48:1456-1459.
16. Nishiguchi M., Matsumoto M., Takao T., Hoshino M., Shimonishi Y., Tsuji S., Takeuchi O., Akira S., Toyoshima K., Seya T. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions. J. Immunol. 2001, 166:2610-2616.
17. Frucht D.M., Fukao T., Bogdan C., Schindler H., O'Shea J.J., Koyasu S. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 2001, 22:556-560.
18. Fricke I., Mitchell D., Mittelstädt J., Lehan N., Heine H., Goldmann T., Böhle A., Brandau S. Mycobacteria induce IFN-gamma production in human dendritic cells via triggering of TLR2. J. Immunol. 2006, 176:5173-5182.
19. Akazawa T., Inoue N., Shime H., Sugiura K., Kodama K., Matsumoto M., Seya T. Adjuvant engineering for cancer immunotherapy: development of a synthetic TLR2 ligand with increased cell adhesion. Cancer Sci. 2010, 101:1596-1603.
20. Takeuchi O., Kawai T., Mühlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
21. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002, 169:10-14.
22. Schneider C., Schmidt T., Ziske C., Tiemann K., Lee K., Uhlinsky V., Behrens P., Sauerbruch T., Schmidt-Wolf I., Mühlradt P., Schmidt J., Märten A. Tumoursuppression induced by macrophage activating lipopeptide in an ultrasound-guided syngeneic pancreatic carcinoma mouse model. Gut 2003, 53:355-363.
23. Akazawa T., Masuda H., Saeki Y., Matsumoto M., Takeda K., Akira S., Tsujimura K., Kuzushima K., Takahashi T., Azuma I., Akira S., Toyoshima K., Seya T. Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice. Cancer Res. 2004, 64:757-764.
24. Baratin M., Roetynck S., Lépolard C., Falk C., Sawadogo S., Uematsu S., Akira S., Ryffel B., Tiraby J.G., Alexopoulou L., Kirschning C.J., Gysin J., Vivier E., Ugolini S. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. U S A 2005, 102:14747-14752.
25. Martinez J., Huang X., Yang Y. Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog. 2010, 6:e1000811.
26. Wenink M.H., Santegoets K.C.M., Broen J.C.A., van Bon L., Abdollahi-Roodsaz S., Popa C., Huijbens R., Remijn T., Lubberts E., van Riel P.L.C.M., van den Berg W.B., Radstake TR.D.J. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop. J. Immunol. 2009, 183:6960-6970.
27. Kikkawa S., Matsumoto M., Sasaki T., Nishiguchi M., Tanaka K., Toyoshima K., Seya T. Complement activation on Mycoplasma fermentans induced mycoplasma clearance from infected cells: Probing the organism with mAbs against M161Ag. Infect. Immun. 2000, 68:1672-1680.
28. Nakao Y., Funami K., Kikkawa S., Taniguchi M., Nishiguchi M., Fukumori Y., Seya T., Matsumoto M. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J. Immunol. 2005, 174:1566-1573.
29. Buwitt-Beckmann U., Heine H., Wiesmüller K.H., Jung G., Brock R., Akira S., Ulmer A.J. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 2006, 281:9049-9057.
30. Rharbaoui F., Drabner B., Borsutzky S., Winckler U., Morr M., Ensoli B., Muhlradt P.F., Guzman C.A. The mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant. Eur. J. Immunol. 2002, 32:2857-2865.
31. Weigt H., Mühlradt P., Emmendörfer A., Krug N., Braun A. Synthetic derived mycoplasmal lipopeptide MALP-2 induces maturation and function of dendritic cells. Immunobiology 2003, 207:1-11.
32. Wittke F., Hoffmann R., Buer J., Dallmann I., Oevermann K., Sel S., Wandert T., Ganser A., Atzpodien J. Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. Br. J. Cancer 1999, 79:1182-1184.
33. Tsuji S., Matsumoto M., Takeuchi O., Akira S., Azuma I., Hayashi A., Toyoshima K., Seya T. Maturation of human dendritic cells by cell-wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin: involvement of Toll-like receptors. Infect. Immun. 2000, 68:6883-6890.
34. Mühlradt P.F., Kiess M., Meyer H., Süssmuth R., Jung G. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect. Immun. 1998, 66:4804-4810.